# Oleg Uritsky

> Oleg Uritsky is a seed investor at Helge Capital, Inc. backing Biotechnology and Software. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Helge Capital, Inc.](https://shizune.co/investors/profile/helge-capital-inc)
- Location: Boston, United States
- Total investments: 16
- Last investment: Apr 2014
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/oleg-uritsky-60014938?authType=NAME_SEARCH&authToken=Epcr&locale=en_US&trk=tyah&trkInfo=clickedVertical%3Amynetwork%2CclickedEntityId%3A131731488%2CauthType%3ANAME_SEARCH%2Cidx%3A1-1-1%2CtarId%3A1462207024747%2Ctas%3Aoleg%20ur
- Website: http://helgecapital.com

Oleg Uritsky is a seed investor at Helge Capital, Inc. in Boston focused on Biotechnology and Software. Oleg Uritsky - Founder & CEO @ Helge Capital, Inc.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $515k–$1.7M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 5 | 31% |
| Software | 4 | 25% |
| Medical Device | 4 | 25% |
| Health Care | 3 | 19% |
| Analytics | 2 | 13% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 38% |
| Convertible Note | 4 | 25% |
| Series A | 3 | 19% |
| Funding Round | 3 | 19% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 14 | 88% |
| Canada | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Skulpt | Skulpt was founded in 2009 by Dr. Seward Rutkove, Neurology Professor of Harvard Medical School, and Dr. Jose Bohorquez, Electrical Engineering PhD from MIT. The company develops hardware and software to help athletes and fitness enthusiasts understand their body composition and give them the intelligence to help optimize their training and reachtheir peak performance. The patented technology, Composition Myography (CM), measures muscle quality and fat content of each major muscle group, giving an unprecedented level of insight into an athlete's body. The Skulpt Muscle Scanner is the world's first and only handheld consumer device that measures individual muscle quality (MQ) and total body fat percentage. The Skulpt app delivers training programs tailored to the unique physique of each user, providing targeted training for optimal results.Initially a medical company, Skulpt has been awarded numerous grants from the National Science Foundation and National Institute of Health to develop CM and validate it through various clinical research trials.Composition Myography has been adopted by dozens of US hospitals and pharmaceutical companies to track the progression of patients with neuromuscular disorders. In 2013, Skulpt began to develop consumer products based on CM technology. Skulpt’s first consumer product, the Aim, was the first-ever electronic to measure muscle quality and the fat content of individual body areas. In March 2016, the company launched the next generation of the Aim, the Chisel Muscle Scanner and an accompanying iOS and Android app. | $1.7M | Seed | Apr 29, 2014 |  |
| Corbus Pharmaceuticals | Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of endocannabinoid system-targeting synthetic drug candidates. The Company's lead product candidate, lenabasum, isa novel, synthetic, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.Corbus is also developing a pipeline of drug candidates from more than 600 novel compounds targeting the endocannabinoid system. The pipeline includes CRB-4001, a 2nd generation, peripherally-restricted, selective cannabinoid receptor type 1 (CB1) inverse agonist. Potential indications for CRB-4001 include NASH, among others. Corbus plans to start a Phase 1 study of CRB-4001 in 2019, intended to be followed by a National Institutes of Health (NIH)-funded proof-of-concept Phase 2 study. | $6.3M |  | Apr 28, 2014 |  |
| SeniorQuote Insurance Services | SeniorQuote Insurance Services was founded over 10 years ago by Bill Haynor, a pioneer in offering affordable life and health insurance solutions to the “Baby Boomer” generation. “The desire to protect seniors like me from the uncertainties of life,” Bill explains simply. “That was my reason for starting SeniorQuote.” Bill personally understandsthe importance of having good health coverage at an affordable price. Not long ago, Bill experienced a series of health issues that forced him to rely on his personal Medicare Supplement Insurance. With heart surgery, emergency appendicitis, open-heart surgery, and knee surgery all in a two year period, Bill quickly exceeded his Medicare coverage, with bills totaling well over $400,000. Click for a look at Bill’s medical bill. “It was unbelievable!” Bill laughs. “I have been so healthy for my whole life, but in that short period of time I was hit from every direction, and I would have had to pay almost half a million dollars in medical bills if I didn’t have Medicare and my Medicare Supplement Insurance plan. Instead, I paid nearly nothing. More than ever before, I see the value we provide to our customers at SeniorQuote.” In the early 1970s, Bill worked with the Waddell and Reed life insurance model which promoted low-cost term life insurance in place of higher cost whole life insurance with the proposition that the difference in premium (premium savings) should be invested in mutual funds for retirement. In the 1980s, Bill was a founder of SelectQuote Insurance Services, one of the first life insurance agencies to offer a term life insurance quote comparison service. The SelectQuote service was designed to assist people by providing affordable rates available from highly-rated life insurance companies. In the 1990s, Bill was a founder of First Union Insurance Services, which offered affordable term life and permanent insurance to support the needs of the bank’s many customers. For the past ten years, Bill has keenly focused on the needs of Baby Boomers; helping them to replace their term life insurance with affordable permanent life insurance, and helping them sort through their Medicare and Medicare Supplement options as they approach the mandatory Medicare age of 65. A senior himself, Bill has become an advocate for seniors. Through SeniorQuote, Bill leads his experienced team of insurance professionals to search for healthcare coverage that fits the specific needs of his customers. |  | Series A | Mar 25, 2014 |  |
| NBD Nanotechnologies | NBD develops coatings and additives to modify surface wetting properties. NBD focuses on coatings and additives that modify surface wettability. NBD's broad product portfolio can influence surface properties for glass and plastic materials to create ultra-durable and functional surface wetting properties.It was founded in 2012 andheadquartered in Brighton, Massachusetts. |  | Convertible Note | Nov 11, 2013 |  |
| ApplyKit | ApplyKit helps manage the college application process from start to finish. Students can take advantage of scholarship offers, a personalized cloud-based suite of tools, and all the additional resources (test prep, tutoring, athletic support) at their fingertips.Partners include: BenchPrep, Veritas Prep, Revolution Prep, Tutor.com, CollegeProwler, Zinch; and non-profit organizations: OneGoal Chicago, Boston Mayor's Youth Line, MindsMatter, and the Chicago Public School system. Launched in March 2013, ApplyKit has already helped thousands of students around the world manage the application process. |  | Seed | Sep 12, 2013 |  |
| PageScience | PageScience has evolved as a source for cookieless page-level scoring and targeting. It pioneered this capability in the healthcare industry 4 years ago and have expanded to other ad categories. Its integration with Appnexus enables the delivery of high-performing pages at a vast scale as they become available. | $515K |  | Aug 29, 2013 |  |
| PageScience | PageScience has evolved as a source for cookieless page-level scoring and targeting. It pioneered this capability in the healthcare industry 4 years ago and have expanded to other ad categories. Its integration with Appnexus enables the delivery of high-performing pages at a vast scale as they become available. | $515K | Seed | Aug 29, 2013 |  |
| Raven360 | Raven360 empowers enterprises of all sizes to control intellectual property and other valuable content as it is shared externally. |  | Series A | Jun 06, 2013 |  |
| ZetrOZ | ZetrOZ is revolutionizing the ultrasound industry by introducing proprietary generator technology that is more efficient, more portable, and more economically viable than any ultrasound generator presently available. |  | Series A | Apr 21, 2013 |  |
| Respiratory Motion | Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. |  | Convertible Note | Mar 01, 2013 |  |

10 of 16 investments shown.

## Co-investors
- [Fort Point Angels](https://shizune.co/investors/profile/fort-point-angels) — VC Fund, 5 deals together
- [Beta Fund](https://shizune.co/investors/profile/beta-fund) — VC Fund, 2 deals together
- [Cherrystone Angel Group](https://shizune.co/investors/profile/cherrystone-angel-group) — VC Fund, 2 deals together
- [Angel Investor Forum](https://shizune.co/investors/profile/angel-investor-forum-ct) — VC Fund, 1 deal together
- [Caerus Ventures](https://shizune.co/investors/profile/caerus-ventures) — VC Fund, 1 deal together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 1 deal together

## About Helge Capital, Inc.

VC Fund · Boston, United States

Multi-asset investment company under a “family office” structure.

1 contacts available at Helge Capital, Inc..

| Name | Title | Profile |
| --- | --- | --- |
| Oleg Uritsky | Founder & CEO | https://shizune.co/investors/profile/oleg-uritsky |

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors in United States](https://shizune.co/investors/biotech-angel-investors-united-states)
- [Medical Device Angel Investors](https://shizune.co/investors/medical-device-angel-investors)
- [Medical Device Angel Investors in United States](https://shizune.co/investors/medical-device-angel-investors-united-states)

## FAQ

### What does Oleg Uritsky invest in?

Oleg Uritsky invests primarily in Biotechnology, Software and Medical Device startups, most often at Seed and Convertible Note stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Oleg Uritsky's check size?

Oleg Uritsky typically joins rounds of $515k–$1.7M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Oleg Uritsky participates in.

### When did Oleg Uritsky last invest?

The most recent investment recorded for Oleg Uritsky closed in Apr 2014. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co